Published in Health Business Week, October 2nd, 2009
A vaccine is expected to be available to the public in October. Various clinical vaccine trials have begun, some under the direction of the National Institutes of Health and others by manufacturers under contract with Health and Human Services.
The H1N1 vaccine itself will be provided at no cost by the federal government. Capital BlueCross is focusing on paying the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.